Predicting Drug-Disease Association Based on Ensemble Strategy

17Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Drug repositioning is used to find new uses for existing drugs, effectively shortening the drug research and development cycle and reducing costs and risks. A new model of drug repositioning based on ensemble learning is proposed. This work develops a novel computational drug repositioning approach called CMAF to discover potential drug-disease associations. First, for new drugs and diseases or unknown drug-disease pairs, based on their known neighbor information, an association probability can be obtained by implementing the weighted K nearest known neighbors (WKNKN) method and improving the drug-disease association information. Then, a new drug similarity network and new disease similarity network can be constructed. Three prediction models are applied and ensembled to enable the final association of drug-disease pairs based on improved drug-disease association information and the constructed similarity network. The experimental results demonstrate that the developed approach outperforms recent state-of-the-art prediction models. Case studies further confirm the predictive ability of the proposed method. Our proposed method can effectively improve the prediction results.

Cite

CITATION STYLE

APA

Wang, J., Wang, W., Yan, C., Luo, J., & Zhang, G. (2021). Predicting Drug-Disease Association Based on Ensemble Strategy. Frontiers in Genetics, 12. https://doi.org/10.3389/fgene.2021.666575

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free